Exogenous FGF4 decreases osteogenic differentiation of mESCs. by Sung-Ho Kook (445098)

Pretreatment with terazosin (0.5, 1 mg/kg) reversed the decrease in EEG amplitude produced by modafinil (90 mg/kg, i.p.). by Chang-Rui Chen (467755)

“…The increase in EEG amplitude may be interpreted as synchronization and a decrease in EEG can be interpreted as a desynchronization. …”

DNMT inhibition decreased PcG expression. by Ah-Young So (221707)

Decrease of mitochondrial protein levels in human OPMD muscle biopsies. by Aymeric Chartier (713911)

Decrease in GABA_B expression in APP mice. by Ksenia V. Kastanenka (3692380)

AMS scores decrease over three days at high-altitude. by Erica C. Heinrich (6832055)

Decrease of GFP-TbAtg8 fluorescence during starvation. by Remo S. Schmidt (546946)

Subsystems and pathways enriched or decreased within fecal microbiome from Control and ATB groups before induction of colitis. by Peris Mumbi Munyaka (830957)

Exogenous activation of BMP signaling decreases apoptosis in POb cells. by Shuli Li (24534)

“…<p>(A) Histogram illustrating a time-course of Caspase-3 activity performed on FOb and POb cells undergoing osteogenic differentiation with or without exogenous BMP-2 (200 ng/ml). …”

SLAP depletion decreases ubiquitination and degradation of Flt3 receptor. by Julhash U. Kazi (291273)

Class-specific mean decrease in accuracy (MDA) for directed motion and normal-, anomalous- and confined-diffusion. by Thorsten Wagner (1320081)

Effect of i.c.v. infusion of anti-IL-1ra neutralizing antibody on poly I:C-induced decreased spontaneous activity. by Masanori Yamato (534076)

PGRN decreased Dectin-2 expression on the surface of macrophages and neutrophils. by Jiayu Liu (3951515)

Plasma CNAs levels decrease after anti-malarial chemotherapy. by Bernardo S. Franklin (220946)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Subjects:

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Su(H) and RBPJ AOS variants decrease DNA binding. by Ellen K. Gagliani (11478756)

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Subjects:

Knockdown of Tsg101 and Alix decrease the production of infectious OROV. by Natalia S. Barbosa (5172338)

S100A9 treatment decreases the secretion of pro-inflammatory cytokines (A) 5 days after LPS injection, sera were collected and tested for IL-6 by ELISA. by Annabelle Cesaro (112070)